Vasculitis & polymyalgia rheumatica

Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

Persistently positive and re-positive ANCA and infections predict clinical relapse in AAV, especially in patients with MPO-AAV and renal involvement.

Study context

Population
Newly diagnosed Antibody-associated Vasculitis (AAV), Affiliated Hospital of Qingdao University, January 2016 through November 2021
Participants
132 participants
Exposure
ANCA patterns and infections as predictors of clinical relapse
Outcome
Clinical relapse
Methodological detailssingle-centre, univariate and multivariate regression, K-M survival curve
  • Single-centre
  • Univariate and multivariate regression
  • K-M survival curve

Main finding

As reported in the abstract

Clinical relapse, overall population
Hazard ratio (95% CI)P value
Persistent positive patternANCA patterns overall p<0.001
3.352(1.463~7.678)
P = 0.004
Positive conversion pattern
4.760(2.094~10.820)
P < 0.001
Infections
4.684(1.980~11.079)
P < 0.001
Relapse rate highest in the positive conversion group
P < 0.001

Observational data: associations, not effects.

Further findings

Clinical relapse, MPO-AAV (subgroup)

HR (95% CI)P value
Persistent positive patternANCA patterns overall p=0.0014.495 (1.508~13.396)P = 0.007
Positive conversion pattern7.404 (2.652~20.671)P < 0.001
Infections3.594 (1.511~8.547)P = 0.004

Clinical relapse, renal involvement (subgroup)

HR (95% CI)P value
Persistent positive patternANCA patterns overall p=0.0043.618 (1.364~9.592)P = 0.01
Positive conversion pattern4.492 (1.778~11.352)P < 0.001
Infections7.791 (2.511~24.174)P < 0.001

Clinical relapse, without renal involvement (subgroup)

ANCA patterns and infections not significantly associated with relapse

Original publication

Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups. Clin Exp Rheumatol. Published 27 July 2022. doi:10.55563/clinexprheumatol/087jdd

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.